Gedeon Richter
Hungary - BudapestBiotechnology
Focus: Gedeon Richter is a 120+ year-old Hungarian pharmaceutical company with 1,001-5,000 employees, focused on small molecules and generics across neurology, cardiovascular, metabolic, and immunology markets.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
0
About Gedeon Richter
AI assessmentNot HiringNo open roles listed right now. Follow Gedeon Richter to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
11 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Post-LOE
Post-loss-of-exclusivity product generating commoditized revenue with limited differentiation or growth potential.
Help build intelligence for Gedeon Richter
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.